Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|66|7|990-997

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.66, Iss.7, 2014-07, pp. : 990-997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1456-1464

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use and Spending for Biologic Disease‐Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 9, 2015-09 ,pp. : 1210-1218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

By Hochberg Marc C.   Berry Scott   Broglio Kristine   Rosenblatt Lisa   Nadkarni Anagha   Trivedi Digisha   Hebden Tony  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1213-1222

Informa Healthcare

Access to resources Recommend Favorite

Differential risk of herpes zoster infection with biologic agent use in rheumatoid arthritis: comment on the article by Yun et al

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 7, 2015-07 ,pp. : 1041-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis

By Turkstra E.   Ng S.-K.   Scuffham P.A.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1885-1897

Informa Healthcare

Access to resources Recommend Favorite